Luisa Gorza Selected Research

Atrophic Muscular Disorders

10/2021	Chronic Systemic Curcumin Administration Antagonizes Murine Sarcopenia and Presarcopenia.
6/2014	The stress protein/chaperone Grp94 counteracts muscle disuse atrophy by stabilizing subsarcolemmal neuronal nitric oxide synthase.
12/2010	Effects of inactivity on human muscle glutathione synthesis by a double-tracer and single-biopsy approach.
8/2009	A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luisa Gorza Research Topics

Disease

7	Atrophy 12/2021 - 12/2010
7	Muscular Atrophy (Muscle Atrophy) 01/2021 - 08/2009
4	Atrophic Muscular Disorders 10/2021 - 08/2009
2	Neoplasms (Cancer) 03/2022 - 10/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2011 - 01/2010
1	Breast Neoplasms (Breast Cancer) 03/2022
1	Sarcopenia 10/2021
1	Asthenia 10/2021
1	Infections 01/2020
1	Heart Failure 10/2013
1	Muscular Diseases (Myopathy) 10/2013
1	Infarction (Infarctions) 01/2013
1	Hypertrophy 01/2013
1	Inflammation (Inflammations) 01/2010
1	Hypoxia (Hypoxemia) 12/2008
1	Cardiomegaly (Heart Hypertrophy) 03/2007
1	Atrial Fibrillation 08/2004
1	Necrosis 05/2003
1	Ischemia 05/2003

Drug/Important Bio-Agent (IBA)

7	glucose-regulated proteinsIBA 03/2022 - 05/2003
7	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2009
5	Protein Isoforms (Isoforms)IBA 12/2021 - 08/2004
3	AntioxidantsIBA 03/2022 - 08/2009
2	CurcuminIBA 10/2021 - 06/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 01/2013
2	Complementary DNA (cDNA)IBA 01/2020 - 06/2014
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 06/2014 - 06/2014
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2014 - 05/2003
2	AntigensIBA 10/2011 - 01/2010
1	Oxidants (Oxidizing Agents)IBA 03/2022
1	IntegrinsIBA 01/2020
1	7-nitroindazoleIBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	Forkhead Box Protein O3IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	EnzymesIBA 12/2018
1	Superoxides (Superoxide)IBA 12/2018
1	NADPH Dehydrogenase (Dehydrogenase, NADP)IBA 12/2018
1	Pharmaceutical PreparationsIBA 06/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2014
1	CytokinesIBA 10/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Homer Scaffolding Proteins (Homer 1)IBA 01/2013
1	MyogeninIBA 01/2013
1	WortmanninIBA 01/2013
1	AutoantigensIBA 10/2011
1	Ligases (Synthetase)IBA 10/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2011
1	AutoantibodiesIBA 10/2011
1	RibonucleoproteinsIBA 10/2011
1	Transfer RNA (tRNA)IBA 10/2011
1	Signal Recognition ParticleIBA 10/2011
1	Glutathione (Reduced Glutathione)IBA 12/2010
1	LipopolysaccharidesIBA 01/2010
1	Indicators and Reagents (Reagents)IBA 01/2010
1	AntibodiesIBA 01/2010
1	CalreticulinIBA 01/2010
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 12/2008
1	Superoxide DismutaseIBA 03/2007
1	Malondialdehyde (Propanedial)IBA 03/2007
1	Hemoglobins (Hemoglobin)IBA 03/2007
1	Troponin IIBA 08/2004
1	Peptide Hydrolases (Proteases)FDA Link 08/2004
1	Propidium (Propidium Iodide)IBA 05/2003
1	CalciumIBA 05/2003
1	Calcimycin (A23187)IBA 05/2003

Therapy/Procedure

3	Bed Rest (Bedrest) 01/2020 - 12/2010
1	Aftercare (After-Treatment) 01/2020
1	Autologous Transplantation 10/2013
1	Therapeutics 10/2013
1	Denervation 01/2013
1	Immunomodulation 01/2010